What is Canopy Growth Corp?
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.
CGC · Verdict
Moderate reward · high risk
CGC's standout is valuation; volatility and profitability weigh on the picture.
Based on 88% data coverage
CGC · Verdict
P/E 20.4×
Weak vs peers
-222% net margin · -49% ROE
-66% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 478.43M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.